The Oxford American Handbook of Urology provides authoritative, point-of-care guidance on all aspects of the field, covering both benign and malignant conditions, as well as medical and surgical management. Incorporating diagnosis and treatment advice from established, published guidelines as well as drawing from the experience of four seasoned urologists, the book's concise and accessible format quickly guides the reader to desired information on common signs and symptoms, incontinence, cancer, infections and infertility plus key information on trauma, urologic emergencies, and pediatric urology. It is an invaluable resource for medical students and residents as well as a useful reference for practitioners.

A concise, up-to-date review of the many new therapies available for the treatment of benign prostatic hypertrophy (BPH). The authors concisely evaluate the latest minimally invasive therapies, as well as time-tested surgical treatments, and review the medical therapies for BPH, namely a-adrenergic antagonists, 5-a reductase inhibitors, and their therapeutic combinations. Additional chapters examine the pathophysiology and natural history of BPH, its epidemiology, and the urodynamic evaluation of lower urinary tract symptoms. A perfect reference source for the practicing urologist seeking sound guidance on the best approach to his patients.

In this issue of Urologic Clinics of North America, guest editor Dr. Adam Feldman brings his considerable expertise to the topic of Biomarkers in Urology. The use of biomarkers in clinical practice can range from screening, to refined detection in an at-risk population, to risk stratification following diagnosis, to prognostication following therapy. A better understanding of tumor biology and genetic heterogeneity will lead clinicians to adopt clinical paradigms that utilize sequences of biomarker assessments. In this issue, key experts help you remain at the forefront of the care of urologic malignancies by providing a timely update on emerging biomarkers in urology. Contains 15 practice-oriented topics including biomarkers in pediatric urology; unleashing the urinary microbiome in benign urologic disease; biomarkers for detection and assessment of clinically significant prostate cancer; biomarkers in testicular cancer: classic tumor markers and beyond; and more. Provides in-depth clinical reviews on biomarkers in urology, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

This book discusses the management of various aspects of the professional life of newly qualified urologists as well as more experienced urologists. It features clear, easy-to-read chapters covering various topics, including clinical and surgical patient care, administrative duties, and research despite the increasing constraints on time and resources in today's hectic practice environment. Navigating Organized Urology: A Practical Guide systematically presents a range of practical strategies for a successful transition from trainee to practising urologist, while also offering more experienced urologists a fresh perspective on efficient management and successful adaptation of their practices for the modern age.

The 3rd edition of this popular text covers all aspects of continence, focusing on continence promotion and measurement of outcomes. The core chapters follow a standard structure for ease of use, and case studies are used throughout to link theory to practice. contains the latest developments in continence treatment incorporates the most recent NHS guidelines on continence management and current legislation includes international perspectives provides a resource for practitioners caring for all client groups in the community and hospital environments a website providing practical documentation along with downloadable charts and examples of continuing professional development activities a new chapter on vulnerable groups, including the frail elderly, and mental health and neurological problems points for continuing professional development at end of every chapter research evidence to guide practice

Management of Erectile Dysfunction in Clinical Practice is a short guide to erectile dysfunction (ED) and its management covering normal function and dysfunction, assessment, treatment options and interventions. ED is a symptom, not a disease and will have underlying causes such as hypertension, coronary artery disease, diabetes, chronic renal impairment, chronic arthritis, chronic alcoholism, multiple sclerosis.

This book will be an essential reference for family practitioners and residents in urology.

The first edition of Male Sexual Function: A Guide to Clinical Management was published in 2001. Since that time, two new oral medications for erectile dysfunction (R) (R) (ED), Vardenafil (Levitra ) and Tadalafil (Cialis ), have been introduced. Links between ED and lower urinary tract symptoms have been postulated, advances in the basic science of erectile physiology have occurred, and the appreciation of ED as a form of endothelial dysfunction and a harbinger of other more potentially lethal forms of vascular disease has become more widespread. In some instances, third-party payers have reduced or eliminated coverage for ED treatments in an attempt to cut costs. They have classified sexual activity as "recreational," "lifestyle," or not medically necessary, but have failed to appreciate the negative consequences of ED, such as depression with all of its ramifications. Male Sexual Function: A Guide to Clinical Management, Second Edition is a comp- hensive overview of the field of male sexual function and includes a chapter on female sexual dysfunction, an emerging field with a very high incidence in the population and an ever-growing following.

Hypospadias is recognised as one the most common congenital malformations in male newborns, resulting in an abnormal opening of urethral meatus. It is regarded as a multifactorial disorder in which interactions between genetics, maternal and environmental factors lead to hypoplastic development of the ventral side of the penis, either dependently or in an interaction with other factors. This book discusses the risk factors of hypospadias. It also examines the epidemiology and surgical outcomes of hypospadias.

This brand new edition describes in detail the tests involved in urodynamic investigation and shows in which clinical areas these tests can help the management of patients. The authors concentrate on common clinical problems and on the presentation of symptom complexes rather than diagnosis, pointing out any limitations and possible artefacts of investigation. * The new edition takes into account the technological innovations that have taken place over the last 10 years, while retaining the original objectives of the first edition. * The subject is presented so simply that a clinician with no previous experience will learn how to use the appropriate equipment in the correct situation. * Urodynamic investigation is described in such detail that it can be accepted in its own right as a fundamental contribution to the management of many patients. After reading this book, clinicians will appreciate the value and limitations of the subject and will have obtained the necessary practical advice on which equipment to use in which situation.

The Essentials in Cytopathology series publishes generously illustrated and user-friendly guides with over 100 full color images that illustrate principles and practice in Cytopathology for pathologists and clinicians. Cytologic Detection of Urothelial Lesions by Dorothy L. Rosenthal, MD and Stephen S. Raab, MD is the second volume in the series. This volume will present a simple approach to dealing with cellular samples from the urinary tract.

This book contains all you need to know about the prostate from its anatomy to the most recent sophisticated robotic technical procedures. This book provides a comprehensive understandable account of benign and malignant prostate conditions, and is designed to be undemanding yet thorough and informative. Medical students will find this book useful because of its concise, easy-to-follow format, in addition to its depth and breadth of knowledge. Interns and residents, as well as practising physicians and family doctors will consider it an efficient and current reference. Each chapter is self contained to make it easier to obtain information about a particular topic without having to refer to the whole book. The book is superbly illustrated throughout in order to enhance the clarity and understanding of the contents. Over 1500 references are cited for those who wish to have a more in-depth insight. The text and references are up to-date and include the most recent innovations, ensuring that the manuscript will remain relevant for some years to come. More than 30 qualified medical practitioners have contributed to the authorship about aspects with which they are clinically involved on a regular daily basis. Some are renowned experts in their field. The book contains 15 chapters. Six chapters are devoted to the benign prostate and provide practical advice regarding diagnosis and treatment. The remaining nine chapters are devoted to the detection, diagnosis, prognosis, treatment and outcomes of prostatic cancer, which is the most common tumour found in men.

This book comprehensively reviews the potential of focal therapy and discusses why the changing face of prostate cancer warrants a change in the way we treat men with the disease. It deals with the mechanisms by which disease can be localized within the gland and then the different technologies used for focal ablation. Bringing together eminent contributors in one accessible reference, this book introduces focal therapy to all urologists, oncologists, and radiologists who are involved in the treatment of men with prostate cancer.

Overactive Bladder: Practical Management provides urologists, gynecologists and other health practitioners with a comprehensive clinical guide to this very common problem, resulting in a perfect resource to consult time and time again. Beginning with an introductory section covering the definition and pathophysiolgy of OAB, it then moves on to cover evaluation, first-line management, second-line management and finally surgery. Well-illustrated throughout, each chapter begins with a key points box outlining the most important take-home messages. Also included are clear management algorithms to aid decision-making, 'Do's and Don't' boxes to help avoid errors made, key references to the top journal articles, and the very latest guidelines from the EAU, AUA and other major urology societies. Chapters are written by the top names in the field and the entire book is expertly edited by Jacques Corcos, John Heesakkers and Scott MacDiarmid. The result is a consistent, comprehensive and fully up to date approach to OAB, providing urologists managing patients with this condition with rapid access, specialist clinical guidance.

This book presents review articles in the study of genitourinary medicine. Topics include basic research that investigates the epigenetic mechanisms in urogenital cancers; the role of matrix metalloproteinases in urothelial cancers; the role of toll-like receptor genes in prostate cancers; recent emerging and novel treatment modalities in advanced metastatic renal cell and bladder carcinomas; novel mouse models for studying malformations in the genitourinary tract; the role of tissue engineering in genitourinary regenerative medicine; and clinical management of patients with Vesicoureteric reflux. Apart from the very well-known Wilms tumour (a form of paediatric hereditary kidney tumours), little is known about paediatric nephritic syndrome and their genetic causes and clinical manifestations. Hence, a special chapter has been included that describes the recent genetic technologies that identify gene mutations in patients with paediatric nephritic syndrome. The specific gene mutations found in these patients are often associated with rapid renal failures, disease progression and poor survival outcome. Each of the articles presented by authors from all over the world are renowned and experts in their own field of research. The authors are based either in research and/or a clinical setting and the articles are only a summary of the view points of each of these authors.

If you (or a loved one) have recently been diagnosed with prostate cancer, danger lies ahead. Efforts will be made to either treat it unnecessarily or with procedures with risks of side effects so severe you will regret it. The Prostate Cancer Industry is a vast array of medical device manufacturers, heath care facilities, physicians and others who generate over a billion dollars annually from treating prostate cancer of which only 20% is actually life threatening. Efforts will be made to scare you into believing you need immediate treatment with most of you being encouraged to have surgery or other treatment provided by the urologist who diagnosed your prostate cancer or an associate. DON'T RUSH INTO TREATMENT until you have obtained an independent second or third opinion from a medical oncologist or internist unrelated to the physician who diagnosed it. To survive prostate cancer AND the prostate cancer industry you must educate yourself on prostate cancer and the different ways it can be treated. Keep in mind that what is in your doctor's best interest may not always be in your best interest. The author selected the non-invasive treatment of proton therapy because of its established effectiveness and least risk of serious side effects. He describes his surprisingly pleasant journey through prostate treatment and encourages you to consider proton therapy as your treatment.

This book describes the current status of vascular access for patients with end-stage renal failure who require dialysis. The book highlights controversial areas and problems and describes differences in practice in USA and Europe. Vascular Access is the Achilles heel of dialysis. In the United States and Europe in 1999 there were in access of 400,000 patients maintained on dialysis. The success of this life sustaining procedure is dependant on being able to successfully access the circulation and obtain blood flows of between two and five hundred mls per minute three times a week. In 1964 Cimino and Brescia described what remains today the premier form of vascular access. Not long after the development of the Cimino Brescia fistula it became apparent that there were patients in whom it was either impossible or extremely difficult to create an adequate fistula for dialysis. As dialysis technology has been applied to older and sicker patients this trend has continued, such that in the United States the majority of patients starting dialysis do not have a primary fistula. The maintenance of long-term vascular access in patients who do not have a primary fistula requires considerably increased effort. In recent years a number of innovations have considerably increased the success of long- term vascular access in these patients. This book brings together these developments, including strategies to prospectively detect impending vascular access failure, and strategies to pre-emptively prevent graft failure. Simultaneously with these developments there have been dramatic improvements in our understanding of the pathophysiology of graft failure, this improved understanding of the biology of access failure are beginning to bring to the clinical arena newer strategies to delay graft failure.

Sphincters prove effective in the mediation of the entrance or release of liquids and fluids. Many sphincters are used everyday in the normal course of digestion and vision. In this book, the authors present topical research in the study of the properties, types and applications of sphincters. Some of the topics discussed include the lower oesophageal sphincter; imaging of the internal anal sphincter; the role of artificial urinary sphincter in female stress urinary incontinence; current and future artificial urinary sphincters in the treatment of male urinary incontinence and the role of satellite cells in the human external urethral sphincter.

As the dialysis population grows, the number of survivors in the second and even third decade of dialysis also increase. These long term survivors face not only the universal complications of dialysis such as anemia and hyparathyroidism but also the consequences of these complications such as the long term cardiovascular problems. They are also subjected to many years of accumulation of "uremic metabolites" resulting in conditions unique to this group of patients, the best example being dialysis amyloid. This book not only describes the causes of morbidity and mortality during the second decade of dialysis but also how these complications can be prevented or minimised. "As you make your bed so you must lie upon it." Survival and quality of life in the second decade and beyond dialysis cannot be divorced from events in the first decade. The longest survival is currently in those patients who have dialysed long hours with tight control of fluid status. Modern dialysis practice and its impact on survival - CAPD, short hour hemodialysis, biocompatible membranes are all discussed in this book.

Der Ultraschall zahlt zu den zentralen Untersuchungstechniken in der Urologie: Das Verfahren ist kostengunstig, verhaltnismassig schnell zu erlernen, praktisch uberall einsetzbar und verursacht keine Strahlenbelastung. Der Atlas bietet einen reichen Fundus an Referenzaufnahmen hoechster Qualitat von haufigen, aber auch von seltenen Befunden. Die Autoren haben die Bilder mit knappen und prazisen Legenden versehen. Komplexe Befunde erlautern sie anhand anschaulicher Grafiken. Der Band eignet sich fur Einsteiger wie fur fortgeschrittene Diagnostiker.

"Treat yourself and your man-root to a thorough and often uproarious read-through. Your health prospects will be pointing at the ceiling in no time."—Peter Moore, former editor of Men's Health

Men are notoriously reluctant to see a doctor. Only three in five men report going for an annual physical, and over 40 percent only ever visit the clinic when their symptoms become unbearable. Many know little or nothing about their bodies, with dire consequences for their well-being.

In Happy Down Below, men’s health specialist Dr. Oliver Gralla provides a clever and highly entertaining remedy to that situation. Packed with colorful anecdotes and quirky illustrations, this cheeky guidebook offers practical tips and clear, accessible explanations for helping men (and women) better understand the male body, learn to care for it, and become more comfortable speaking about it with their doctors when things go wrong. With plenty of relatable metaphors and a light, conversational tone, Dr. Gralla provides simple, research-based answers to questions such as: Do male enhancement pills actually work? Why does erectile dysfunction happen and how is it treated? What is a “normal” penis―and how big is it really? And much, much more.

The world-wide prevalence of sexually transmitted infections (STIs) is a cause of concern for the public and health organisations. Young age of sexual debut, breakdown of relationships, travel, mobility, relationship explorations, social instability, between other socio-economic factors, contribute to the loss monogamous sexual relationships. The resultant multiplicity of sexual relationships predispose to STIs. The Sexually Transmitted Infections book provides an overall practical account for the benefit of generalists and Primary Care physicians, who would encounter the patients' problems first. The emphasis on clinical issues, drawing from the author's 30 years of progressive clinical experience in Primary Care, Urology, Obstetrics and Gynaecology and Venereology, share expertise with those intending to specialise. Patients who wish to acquire unbiased in depth knowledge about sexually transmitted infections, will find answers to their questions. Many of these questions were asked times and times again by patients who shared similar concerns and anxieties. The book covers a wide range of clinical practices and facilities and addresses areas of low resource settings, which will make the account relevant to developing primary health units.

Prostate cancer is the commonest cancer in men. Current treatments include surgery to remove the whole prostate or radiotherapy of the whole prostate. These radical treatments can treat the cancer effectively but often cause unwanted side effects. Meanwhile widespread screening with prostate-specific antigen has led to an increased diagnosis of localised prostate cancer; at the same time, widespread use of abdominal imaging has led to increased detection of renal masses. In response to demand for improved outcomes with reduced side effects, focal therapy has emerged as an important procedure in managing both prostate and renal cancers. It targets individual areas of cancer, reducing unwanted side effects and the amount of damage to collateral tissue. This new method of treatment has major advantages: it involves less radiation, the removal of less tissue and less time spent in hospital. Handbook of Focal Therapy for Prostate and Renal Cancer provides a comprehensive, timely review of targeted ablation methods to treat prostate and renal cancers. It describes the most effective techniques in current practice, with discussion of the selection criteria, ablation technologies and their limitations, and advice on the management of common side effects. The book opens with a summary of the principles of prostate and renal cancer treatment and the mechanisms of focal therapy. Separate sections on prostate and kidney follow, covering the role of focal therapy, side effects and their treatment and follow-up after targeted ablation. Written in a practical, clinically-oriented style, Handbook of Focal Therapy for Prostate and Renal Cancer is the ideal reference for urologists, radiologists and radiation oncologists wishing to employ the latest focal therapy techniques in the care of their patients.

This comprehensive and timely textbook covers all aspects of the evidence-based management of genitourinary cancers and explains the fundamental principles underlying the available diagnostic and treatment approaches, including chemotherapy, radiotherapy, immunotherapy, and surgery. For each type of cancer - prostate, bladder, renal, testicular, and penile, plus rare urologic malignancies - clinical presentation, diagnosis, and treatment strategies are described in detail and information is provided on etiology, epidemiology, risk factors, and pathology, including TNM classification. Careful attention is also devoted to the complications that may be encountered when treating urologic malignancies and to the management of these complications. The text is complemented by the inclusion of numerous high-definition photographs and illustrations. Urologic Oncology will be a valuable reference and source of guidance for all oncologists, urologists and practitioners in related disciplines who treat patients with urologic cancers.